Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. [electronic resource]
Producer: 20121203Description: 571-8 p. digitalISSN:- 1941-3297
- Age Factors
- Aged
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Biphenyl Compounds -- therapeutic use
- Chi-Square Distribution
- Comorbidity
- Female
- Health Status Disparities
- Heart Failure -- diagnosis
- Hospitalization
- Humans
- Irbesartan
- Male
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Proportional Hazards Models
- Risk Assessment
- Risk Factors
- Sex Factors
- Stroke Volume
- Tetrazoles -- therapeutic use
- Time Factors
- Treatment Outcome
- Ventricular Function, Left
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.